The U.S. Food and Drug Administration (FDA) has granted Celcuity’s drug Gedatolisib Priority Review designation for its New Drug Application (NDA).
Show original
Bitget offers one-stop trading for cryptocurrencies, stocks, and gold. Trade now!
A welcome pack worth 6200 USDT for new users! Sign up now!
According to documents submitted to the U.S. Securities and Exchange Commission (SEC), the Prescription Drug User Fee Act (PDUFA) target date for the application has been set for July 17, 2026. This marks a key step in the drug's regulatory approval process and is expected to accelerate its path to market.
0
0
Disclaimer: The content of this article solely reflects the author's opinion and does not represent the platform in any capacity. This article is not intended to serve as a reference for making investment decisions.
Understand the market, then trade.
Bitget offers one-stop trading for cryptocurrencies, stocks, and gold.
Trade now！
You may also like
XRP Price Saved as It Bounces Over $1.3
UToday•2026/09/15 08:15
Piedmont Realty Trust Prices $200 Million Private Debt Offering
MT newswire•2026/09/15 08:11
2-Yr Benchmark Govt Yields - Germany vs Other Nations
Dow Jones•2026/09/15 08:10
Crypto prices
More
Bitcoin
BTC
$76,778.64
-1.23%
Ethereum
ETH
$2,470.61
-1.98%
Tether USDt
USDT
$0.9996
+0.02%
BNB
BNB
$714.76
-1.34%
XRP
XRP
$1.39
+0.10%
USDC
USDC
$0.9999
+0.01%
Solana
SOL
$100.19
-1.30%
TRON
TRX
$0.3374
-0.48%
Hyperliquid
HYPE
$78.58
-1.50%
Zcash
ZEC
$1,136.58
-0.19%
How to buy BTC
Bitget lists BTC – Buy or sell BTC quickly on Bitget!
Trade now
Become a trader now?A welcome pack worth 6200 USDT for new users!
Sign up now